Catalio Capital Management

A New York-based investment firm focused on the full lifecycle of healthcare and life sciences investing across private, public, and credit markets.

Venture Capital Active New York, United States Est. 2020
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—

About

Catalio Capital Management is a New York-based investment firm focused on the full lifecycle of healthcare and life sciences investing across private, public, and credit markets. The firm invests across the capital structure and stages, provides capital through private equity, structured opportunities, public equities, and co-investments, and works with portfolio companies from inception to exit. Catalio emphasizes scientific and clinical due diligence through a network of Venture Partners.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

Portfolio by sector

Health Tech & Life Sciences3

Q&A

What is Catalio Capital Management's primary investment focus?
Catalio Capital Management primarily focuses on the Health Tech & Life Sciences sector, with all three of its listed portfolio companies operating in this area.
Can you name some of Catalio Capital Management's portfolio companies?
Catalio Capital Management's portfolio includes Immunai, which specializes in peripheral tissue analysis, and Insightec, known for MR-guided focused ultrasound systems.
What was Catalio Capital Management's most recent investment?
Catalio Capital Management participated in a G Round for Insightec in October 2024, which raised a total of $592.9M.
When did Catalio Capital Management make its investment in Immunai?
Catalio Capital Management invested in Immunai's B Round in February 2021, a round that raised $295M.
What is the typical investment range for Catalio Capital Management?
Catalio Capital Management's investment range is between $60M and $150M.
Has Catalio Capital Management made any investments in 2024?
Yes, Catalio Capital Management made two investments in 2024: a D Round for Orasis Pharmaceuticals in June and a G Round for Insightec in October.
Which funding stages does Catalio Capital Management typically participate in?
Catalio Capital Management has participated in A, D, and G funding rounds, according to its investment history.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2020